Azelis Group (AZE) Aktienübersicht
Die Azelis Group NV ist im Vertrieb und Verkauf von Spezialchemikalien und Lebensmittelzutaten tätig. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 2/6 |
| Künftiges Wachstum | 2/6 |
| Vergangene Leistung | 2/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 2/6 |
AZE Community Fair Values
Create NarrativeSee what 17 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Azelis Group NV Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | €11.65 |
| 52-Wochen-Hoch | €13.66 |
| 52-Wochen-Tief | €6.88 |
| Beta | 0.54 |
| 1 Monat Veränderung | 13.77% |
| 3 Monate Veränderung | 10.11% |
| 1 Jahr Veränderung | -10.73% |
| 3 Jahre Veränderung | -40.98% |
| 5 Jahre Veränderung | n/a |
| Veränderung seit IPO | -58.39% |
Aktuelle Nachrichten und Updates
Narrative-Update • Jul 30
AZE: Margin Recovery And Dividend Visibility Will Support Repriced Risk Outlook
Analysts have nudged their fair value estimate for Azelis Group higher to €13.11 from €12.48, reflecting a slightly more constructive view on revenue growth, profit margins and risk after recent price target increases from €7.50 to €10.50 and from €10.50 to €12. The latest ratings suggest that key risks are now better reflected in the share price.
Narrative-Update • Jul 14
AZE: Fairly Priced Outlook Will Test Execution And Dividend Support
Analysts now see Azelis Group's fair value edging up from €9.50 to €10.00, in line with recent price target increases to €10.50 and €12 that reflect a view that key risks are already reflected in the stock. Analyst Commentary Recent research on Azelis Group points to a more balanced stance, with price targets in a relatively tight range and an emphasis on how much risk is already reflected in the current share price.Narrative-Update • Jun 30
AZE: Balanced Risk View Will Test Premium P/E As Governance Evolves
The analyst price target for Azelis Group has been raised from €7.78 to €9.50, as analysts point to updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, supported by recent price target increases from €7.50 to €10.50 and then to €12 in Street research. Analyst Commentary Recent Street research on Azelis Group highlights a more balanced stance, with some price targets raised but overall ratings staying cautious.
Narrative-Update • Jun 15
AZE: Dividend Policy And Buybacks Will Support A More Constructive Outlook
Narrative Update: Azelis Group Analysts have lifted their price target for Azelis Group to €12 from €10.50, reflecting updated views on the stock's risk profile and earnings potential following recent research. What's in the News The AGM on 13 May 2026 approved a gross dividend of €0.226 per share for the 2025 financial year (net €0.158 per share after 30% Belgian withholding tax).Recent updates
Narrative-Update • Jul 30
AZE: Margin Recovery And Dividend Visibility Will Support Repriced Risk Outlook
Analysts have nudged their fair value estimate for Azelis Group higher to €13.11 from €12.48, reflecting a slightly more constructive view on revenue growth, profit margins and risk after recent price target increases from €7.50 to €10.50 and from €10.50 to €12. The latest ratings suggest that key risks are now better reflected in the share price.Narrative-Update • Jul 14
AZE: Fairly Priced Outlook Will Test Execution And Dividend Support
Analysts now see Azelis Group's fair value edging up from €9.50 to €10.00, in line with recent price target increases to €10.50 and €12 that reflect a view that key risks are already reflected in the stock. Analyst Commentary Recent research on Azelis Group points to a more balanced stance, with price targets in a relatively tight range and an emphasis on how much risk is already reflected in the current share price.Narrative-Update • Jun 30
AZE: Balanced Risk View Will Test Premium P/E As Governance Evolves
The analyst price target for Azelis Group has been raised from €7.78 to €9.50, as analysts point to updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E, supported by recent price target increases from €7.50 to €10.50 and then to €12 in Street research. Analyst Commentary Recent Street research on Azelis Group highlights a more balanced stance, with some price targets raised but overall ratings staying cautious.Narrative-Update • Jun 15
AZE: Dividend Policy And Buybacks Will Support A More Constructive Outlook
Narrative Update: Azelis Group Analysts have lifted their price target for Azelis Group to €12 from €10.50, reflecting updated views on the stock's risk profile and earnings potential following recent research. What's in the News The AGM on 13 May 2026 approved a gross dividend of €0.226 per share for the 2025 financial year (net €0.158 per share after 30% Belgian withholding tax).Narrative-Update • Jun 01
AZE: Dividend Policy And Capital Actions Will Support A More Constructive Outlook
Analysts have raised their price target on Azelis Group to €12 from €10.50, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E that feed into their valuation work. What's in the News Azelis Group plans to pay a gross dividend of €0.226 per share for fiscal year 2025, with an ex dividend date on 29 June 2026, a record date on 30 June 2026, and payment from 1 July 2026 via KBC Bank NV.Narrative-Update • May 16
AZE: Dividend Support And Capital Actions Will Shape A More Constructive Outlook
The analyst price target for Azelis Group has shifted from about €17.35 to €16.00, reflecting updated assumptions on fair value and P/E, alongside recent mixed Street research where some analysts raised targets toward €10.50 to €12 and others trimmed targets to €15. Analyst Commentary Street research on Azelis Group is mixed but includes several clearly bullish signals on valuation and execution.Narrative-Update • Apr 29
AZE: Governance Changes And Share Buybacks Will Pressure Premium P/E Expectations
Azelis Group's analyst price targets have shifted to a range between €10.50 and €15, reflecting updated views on fair value, discount rates, revenue growth and profit margins as analysts recalibrate expectations for the stock. Analyst Commentary Recent price target revisions for Azelis Group sit between €10.50 and €15, with some bearish analysts trimming expectations and others only making modest upward adjustments.Narrative-Update • Apr 15
AZE: Downgrades And Governance Changes Will Pressure Premium P/E Expectations
Analysts have nudged the fair value estimate for Azelis Group higher to €7.60 from €7.50, citing updated assumptions on revenue growth and discount rates, along with mixed changes in Street price targets that now range from €10.50 to €15. Analyst Commentary Recent research shows a split view on Azelis Group, with some Bearish analysts trimming expectations while others take a more neutral stance.Narrative-Update • Mar 31
AZE: Dividend Clarity And Refined Assumptions Will Support A More Constructive Outlook
The updated analyst price target for Azelis Group moves slightly lower to about €17.35 from roughly €17.70. Analysts point to refined assumptions on discount rates, revenue growth, profit margins and future P/E to support the change.Narrative-Update • Mar 17
AZE: Higher Dividend Visibility Will Support A More Constructive Outlook
The analyst price target for Azelis Group has been reduced from about €24.00 to roughly €17.70, as analysts factor in updated assumptions for discount rates, revenue growth, profit margins and future P/E, along with recent mixed Street research where some firms trimmed targets while others made only modest upward adjustments. Analyst Commentary Street research on Azelis Group has been mixed, but there are pockets of optimism that stand out in the recent updates.Narrative-Update • Mar 03
AZE: Margin Recovery And Dividend Visibility Will Support Future Upside Potential
Azelis Group’s analyst fair value estimate has been trimmed from €13.20 to about €12.48. This reflects a reset in price targets after some analysts reduced their outlooks toward the mid-teens and low double digits, while still factoring in updated views on growth, margins and future P/E levels.Narrative-Update • Feb 17
AZE: Margin Recovery Will Support Upside Despite Recent Discounted Reset
Analysts have trimmed their price target for Azelis Group from about €14.27 to €13.20, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples following recent research, including the latest Kepler Cheuvreux downgrade. Analyst Commentary Recent research points to a more cautious stance on Azelis Group, with the latest price target reset to about €13.20.Narrative-Update • Feb 03
AZE: Downgrades And Sector Headwinds Will Pressure Premium P/E Expectations
Azelis Group’s analyst price target has shifted lower to about €7.50 from €10.00 as analysts factor in a higher discount rate, more cautious revenue growth assumptions, a lower future P/E multiple, and only a modest adjustment to profit margin expectations following recent downgrades. Analyst Commentary Bearish analysts are resetting expectations around Azelis Group, with several research notes pointing to a more cautious stance on the shares.Narrative-Update • Jan 20
AZE: Margin Recovery Is Expected To Support Re-Rating Despite Sector Caution
Narrative update Analysts have trimmed their price target for Azelis Group from about €15.71 to roughly €14.27, reflecting more cautious assumptions on growth, margins and future P/E following a series of rating and target cuts from European brokers. Analyst Commentary Recent research updates on Azelis Group have generally moved in a more cautious direction, with multiple firms lowering ratings and price targets.Narrative-Update • Jan 06
AZE: Fair View Balances Sector Headwinds With Prospects For 2025 Margin Recovery
We are lowering our Azelis Group fair value estimate to €10 from €16, reflecting analysts' reduced price targets and more cautious assumptions on growth, margins and sector conditions. Analyst Commentary Recent Street research on Azelis Group has turned more cautious, with several bearish analysts revising ratings and trimming price targets.Narrative-Update • Dec 22
AZE: Margins Are Expected To Recover As Industry Pressures Gradually Ease
The analyst price target for Azelis Group has been trimmed slightly to EUR 15.71 from EUR 15.82 as analysts factor in softer revenue growth and margins amid ongoing industry headwinds, partially offset by expectations for a gradual recovery and resilient valuation multiples. Analyst Commentary Analyst sentiment on Azelis Group has become more mixed, with a growing divergence between those who see the current downturn as an attractive entry point and those who expect industry headwinds to constrain performance for longer.Narrative-Update • Dec 08
AZE: Demand And Margins Will Recover From Current Cyclical Weakness
Azelis Group's analyst price target has been trimmed from about EUR 16.25 to approximately EUR 15.82, as analysts factor in sector wide pressure on European chemicals, more cautious views on diversified distributors, and expectations for only gradual recovery in growth and margins despite some supportive initiation coverage. Analyst Commentary Recent Street research on Azelis reflects a mixed backdrop, with several downward rating and target revisions offset by selective bullish initiation.Narrative-Update • Nov 24
AZE: Demand And Margins Will Rebound From Trough In 2025
Azelis Group’s analyst fair value target has been lowered from €17.39 to €16.25. Analysts point to ongoing industry headwinds and recent sector downgrades as key drivers of the more cautious outlook.Analyseartikel • Nov 14
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking
It's not a stretch to say that Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 14x right now seems...Narrative-Update • Nov 07
AZE: Earnings Momentum Will Strengthen As Industry Conditions Improve In 2025
Azelis Group's analyst price target was revised downward by EUR 0.50 to EUR 17.39. This reflects analysts' expectations of slower revenue growth and persistent margin pressures in the near term.Narrative-Update • Oct 24
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
The analyst price target for Azelis Group has decreased from €18.50 to €17.89. This change reflects cautious sentiment among analysts amid industry headwinds and anticipated margin pressures through mid-2026.Narrative-Update • Oct 10
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Azelis Group's analyst price target has been reduced from €19.13 to €18.50. Analysts cite ongoing industry headwinds and reduced earnings forecasts as reasons for the cautious outlook.Analyseartikel • Sep 30
Here's Why Azelis Group (EBR:AZE) Has A Meaningful Debt Burden
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Narrative-Update • Sep 26
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Analysts have trimmed Azelis Group’s price target to €19.13, citing weaker Q2 earnings, a more conservative sector outlook, and increased market risk, partially offset by sustained strength in specialty testing. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.Narrative-Update • Sep 05
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Analysts have trimmed their earnings estimates and near-term growth outlook for Azelis Group amid sector challenges and softer fundamentals, resulting in a stable consensus price target of €19.56. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.Analyseartikel • Jul 13
Azelis Group (EBR:AZE) Is Experiencing Growth In Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...Analyseartikel • Jun 17
Unpleasant Surprises Could Be In Store For Azelis Group NV's (EBR:AZE) Shares
Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 18.3x might make it look like a sell right now...Analyseartikel • May 30
Azelis Group's (EBR:AZE) Dividend Will Be Increased To €0.161
Azelis Group NV ( EBR:AZE ) has announced that it will be increasing its dividend from last year's comparable payment...Analyseartikel • May 27
An Intrinsic Calculation For Azelis Group NV (EBR:AZE) Suggests It's 39% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Azelis Group fair value estimate is €23.79 Azelis Group is...Analyseartikel • May 09
Azelis Group's (EBR:AZE) Shareholders Will Receive A Bigger Dividend Than Last Year
Azelis Group NV ( EBR:AZE ) will increase its dividend from last year's comparable payment on the 1st of July to...Analyseartikel • Apr 25
Azelis Group (EBR:AZE) Is Paying Out A Larger Dividend Than Last Year
Azelis Group NV ( EBR:AZE ) has announced that it will be increasing its dividend from last year's comparable payment...Analyseartikel • Mar 28
Azelis Group (EBR:AZE) Shareholders Will Want The ROCE Trajectory To Continue
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analyseartikel • Mar 10
Azelis Group NV Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Azelis Group NV ( EBR:AZE ) came out with its annual results last week, and we wanted to see how the business is...
Neues Narrative • Feb 23
Life Sciences Recovery And Digitalization Investments Will Improve Future Efficiency
Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies.Analyseartikel • Feb 23
Is Azelis Group (EBR:AZE) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Jan 27
Are Investors Undervaluing Azelis Group NV (EBR:AZE) By 35%?
Key Insights Azelis Group's estimated fair value is €29.27 based on 2 Stage Free Cash Flow to Equity Current share...Analyseartikel • Jan 06
Azelis Group NV's (EBR:AZE) Earnings Haven't Escaped The Attention Of Investors
When close to half the companies in Belgium have price-to-earnings ratios (or "P/E's") below 12x, you may consider...Analyseartikel • Nov 23
There's Been No Shortage Of Growth Recently For Azelis Group's (EBR:AZE) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Oct 18
Azelis Group (EBR:AZE) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Sep 30
With Azelis Group NV (EBR:AZE) It Looks Like You'll Get What You Pay For
With a price-to-earnings (or "P/E") ratio of 28.8x Azelis Group NV ( EBR:AZE ) may be sending very bearish signals at...Analyseartikel • Aug 24
Azelis Group NV's (EBR:AZE) Intrinsic Value Is Potentially 50% Above Its Share Price
Key Insights The projected fair value for Azelis Group is €27.87 based on 2 Stage Free Cash Flow to Equity Current...Analyseartikel • Aug 04
Azelis Group NV Just Missed EPS By 28%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that Azelis Group NV ( EBR:AZE ) released its interim result to the market. The early...Analyseartikel • Jul 26
We Like These Underlying Return On Capital Trends At Azelis Group (EBR:AZE)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...Analyseartikel • Jun 14
Azelis Group (EBR:AZE) Will Pay A Smaller Dividend Than Last Year
Azelis Group NV's ( EBR:AZE ) dividend is being reduced from last year's payment covering the same period to €0.154 on...Analyseartikel • Jun 09
Here's Why Azelis Group (EBR:AZE) Can Manage Its Debt Responsibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • May 22
Azelis Group's (EBR:AZE) Dividend Is Being Reduced To €0.154
Azelis Group NV's ( EBR:AZE ) dividend is being reduced from last year's payment covering the same period to €0.154 on...Analyseartikel • Apr 22
Calculating The Intrinsic Value Of Azelis Group NV (EBR:AZE)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Azelis Group fair value estimate is €27.25 With €22.80 share...Analyseartikel • Apr 04
Investor Optimism Abounds Azelis Group NV (EBR:AZE) But Growth Is Lacking
Azelis Group NV's ( EBR:AZE ) price-to-earnings (or "P/E") ratio of 24.8x might make it look like a strong sell right...Aktionärsrenditen
| AZE | BE Trade Distributors | BE Markt | |
|---|---|---|---|
| 7D | 3.4% | 1.6% | 0.5% |
| 1Y | -10.7% | 14.4% | 22.2% |
Rendite im Vergleich zur Industrie: AZE unter dem Niveau der Branche Belgian Trade Distributors , die im vergangenen Jahr eine Rendite von 15.7% erzielte.
Rendite vs. Markt: AZE hinter dem Markt Belgian zurück, der im vergangenen Jahr eine Rendite von 22.5 erzielte.
Preisvolatilität
| AZE volatility | |
|---|---|
| AZE Average Weekly Movement | 4.1% |
| Trade Distributors Industry Average Movement | 4.5% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in BE Market | 7.8% |
| 10% least volatile stocks in BE Market | 2.2% |
Stabiler Aktienkurs: AZE hatte in den letzten 3 Monaten im Vergleich zum Belgian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: AZEDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1996 | 4,000 | Anna Bertona | www.azelis.com |
Die Azelis Group NV ist im Vertrieb und Verkauf von Spezialchemikalien und Lebensmittelzutaten tätig. Das Unternehmen vertreibt Spezialchemieprodukte, die in den Bereichen Biowissenschaften, wie Körperpflege, Haushaltspflege, industrielle Reinigung, Pharmazeutika, Gesundheitswesen, Lebensmittel und Ernährung, Tierernährung, Aromen und Duftstoffe sowie landwirtschaftliche Umweltlösungen, und Industriechemikalien, wie CASE, fortschrittliche Materialien und Zusatzstoffe, Schmierstoffe, Metallbearbeitungsflüssigkeiten, Elektronik, Grund- und Feinchemikalien, Textilien, Leder und Papier verwendet werden. Das Unternehmen ist in Europa, dem Nahen Osten und Afrika sowie in Nord- und Südamerika und im asiatisch-pazifischen Raum tätig.
Azelis Group NV's Grundlagenzusammenfassung
| AZE grundlegende Statistiken | |
|---|---|
| Marktanteil | €2.83b |
| Gewinn(TTM) | €112.80m |
| Umsatz(TTM) | €4.12b |
25.1x
Kurs-Gewinn-Verhältnis 0.7x
Kurs-Umsatz-VerhältnisIst AZE zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| AZE Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | €4.12b |
| Kosten der Einnahmen | €3.16b |
| Bruttogewinn | €955.78m |
| Sonstige Ausgaben | €842.98m |
| Gewinn | €112.80m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 0.46 |
| Bruttomarge | 23.21% |
| Nettogewinnspanne | 2.74% |
| Schulden/Eigenkapital-Verhältnis | 58.7% |
Wie hat sich AZE auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
1.9%
Aktuelle Dividendenrendite49%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/10 07:06 |
| Aktienkurs zum Tagesende | 2026/08/10 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Azelis Group NV wird von 21 Analysten beobachtet. 11 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Gaurav Jain | Barclays |
| James Stewart | Barclays |
| Anil Shenoy | Barclays |